{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:59:57Z","timestamp":1783033197684,"version":"3.54.6"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T00:00:00Z","timestamp":1545004800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["#1520160"],"award-info":[{"award-number":["#1520160"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00330-018-5898-9","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T07:14:02Z","timestamp":1545030842000},"page":"3111-3121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance"],"prefix":"10.1007","volume":"29","author":[{"given":"Hyungjin","family":"Rhee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7949-5402","authenticated-orcid":false,"given":"Myeong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Nyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chansik","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"key":"5898_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales JM, Cardinale V, Carpino G et al (2016) Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol 13:261\u2013280","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5898_CR2","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ (2014) Cholangiocarcinoma. Lancet 383:2168\u20132179","journal-title":"Lancet"},{"key":"5898_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jhbp.154","volume":"22","author":"S Aishima","year":"2015","unstructured":"Aishima S, Oda Y (2015) Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type. J Hepatobiliary Pancreat Sci 22:94\u2013100","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"5898_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000449493","volume":"6","author":"T Ebata","year":"2016","unstructured":"Ebata T, Ercolani G, Alvaro D, Ribero D, Di Tommaso L, Valle JW (2016) Current status on cholangiocarcinoma and gallbladder cancer. Liver Cancer 6:59\u201365","journal-title":"Liver Cancer"},{"key":"5898_CR5","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/PAS.0b013e31802b34b6","volume":"31","author":"S Aishima","year":"2007","unstructured":"Aishima S, Kuroda Y, Nishihara Y et al (2007) Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol 31:1059\u20131067","journal-title":"Am J Surg Pathol"},{"key":"5898_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bpg.2015.02.006","volume":"29","author":"Y Nakanuma","year":"2015","unstructured":"Nakanuma Y, Kakuda Y (2015) Pathologic classification of cholangiocarcinoma: new concepts. Best Pract Res Clin Gastroenterol 29:277\u2013293","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"5898_CR7","first-page":"540","volume":"29","author":"JH Lim","year":"2004","unstructured":"Lim JH, Park CK (2004) Pathology of cholangiocarcinoma. Abdom Imaging 29:540\u2013547","journal-title":"Abdom Imaging"},{"key":"5898_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00534-002-0732-8","volume":"10","author":"S Yamasaki","year":"2003","unstructured":"Yamasaki S (2003) Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 10:288\u2013291","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"5898_CR9","unstructured":"Nakanuma Y, Curado MP, Franceschi S, Gores GJ, Paradis V, Sripa B, Tsui WMS, Wee A (2010) Intrahepatic cholangiocarcinoma. In: Bosman FT, Carneiro F Hruban RH, Theise ND (Eds) WHO classification of tumours of the digestive system, 4th edn. World Health Organization. pp 217\u2013224"},{"key":"5898_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4254\/wjh.v2.i12.419","volume":"2","author":"Y Nakanuma","year":"2010","unstructured":"Nakanuma Y, Sato Y, Harada K, Sasaki M, Xu J, Ikeda H (2010) Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol 2:419\u2013427","journal-title":"World J Hepatol"},{"key":"5898_CR11","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/hep.25595","volume":"55","author":"M Komuta","year":"2012","unstructured":"Komuta M, Govaere O, Vandecaveye V et al (2012) Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology 55:1876\u20131888","journal-title":"Hepatology"},{"key":"5898_CR12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/PAS.0000000000000670","volume":"40","author":"A Hayashi","year":"2016","unstructured":"Hayashi A, Misumi K, Shibahara J et al (2016) Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma. Am J Surg Pathol 40:1021\u20131030","journal-title":"Am J Surg Pathol"},{"key":"5898_CR13","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/modpathol.2017.22","volume":"30","author":"M Akita","year":"2017","unstructured":"Akita M, Fujikura K, Ajiki T et al (2017) Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas. Mod Pathol 30:986\u2013997","journal-title":"Mod Pathol"},{"key":"5898_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/liv.13492","volume":"38","author":"H Rhee","year":"2018","unstructured":"Rhee H, Ko JE, Chung T et al (2018) Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma. Liver Int 38:113\u2013124","journal-title":"Liver Int"},{"key":"5898_CR15","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","volume":"142","author":"JB Andersen","year":"2012","unstructured":"Andersen JB, Spee B, Blechacz BR et al (2012) Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology 142:1021\u20131031 e1015","journal-title":"Gastroenterology"},{"key":"5898_CR16","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","volume":"144","author":"D Sia","year":"2013","unstructured":"Sia D, Hoshida Y, Villanueva A et al (2013) Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 144:829\u2013840","journal-title":"Gastroenterology"},{"key":"5898_CR17","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","volume":"27","author":"JY Liau","year":"2014","unstructured":"Liau JY, Tsai JH, Yuan RH, Chang CN, Lee HJ, Jeng YM (2014) Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features. Mod Pathol 27:1163\u20131173","journal-title":"Mod Pathol"},{"key":"5898_CR18","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","volume":"31","author":"Y Wang","year":"2013","unstructured":"Wang Y, Li J, Xia Y et al (2013) Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 31:1188\u20131195","journal-title":"J Clin Oncol"},{"key":"5898_CR19","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s00268-008-9726-2","volume":"32","author":"K Shirai","year":"2008","unstructured":"Shirai K, Ebata T, Oda K et al (2008) Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 32:2395\u20132402","journal-title":"World J Surg"},{"key":"5898_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/RCT.0000000000000695","volume":"42","author":"JG Nam","year":"2018","unstructured":"Nam JG, Lee JM, Joo I et al (2018) Intrahepatic mass-forming cholangiocarcinoma: relationship between computed tomography characteristics and histological subtypes. J Comput Assist Tomogr 42:340\u2013349","journal-title":"J Comput Assist Tomogr"},{"key":"5898_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1148\/radiol.11101777","volume":"260","author":"SA Kim","year":"2011","unstructured":"Kim SA, Lee JM, Lee KB et al (2011) Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern\u2014correlation with clinicopathologic findings. Radiology 260:148\u2013157","journal-title":"Radiology"},{"key":"5898_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s00330-016-4386-3","volume":"27","author":"N Fujita","year":"2017","unstructured":"Fujita N, Asayama Y, Nishie A et al (2017) Mass-forming intrahepatic cholangiocarcinoma: enhancement patterns in the arterial phase of dynamic hepatic CT\u2014correlation with clinicopathological findings. Eur Radiol 27:498\u2013506","journal-title":"Eur Radiol"},{"key":"5898_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s002619900442","volume":"24","author":"Y Yoshida","year":"1999","unstructured":"Yoshida Y, Imai Y, Murakami T et al (1999) Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging 24:66\u201368","journal-title":"Abdom Imaging"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5898-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-018-5898-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5898-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T19:10:24Z","timestamp":1576523424000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-018-5898-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,17]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["5898"],"URL":"https:\/\/doi.org\/10.1007\/s00330-018-5898-9","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,17]]},"assertion":[{"value":"6 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Myeong-Jin Kim.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"Myeong-Jin Kim is a recipient of a grant from Bayer HealthCare, which is not related to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Some study subjects or cohorts have been previously reported in Rhee et al [].","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 Retrospective\u2022 Observational\u2022 Performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}